Hormonersatztherapie

Benefit (r)evolutionärer Diagnostik und rechtzeitiger Behandlung
Prof. Dr. med. Dipl. Psych. J. M. Wenderlein, Seiten 18-23

  1. Xiao Q. et al. Dietary and Supplemental Calcium Intake and Cardiovascular Disease Mortaly. JAMA Intern Med 2013, online 4, Februar: doi:10.1001/ jamainternmed.2013.3283
  2. Balion C et al.: Vitamin D, cognition, and dementia: a systhemeticrewiew and meta-analysis. Neurology 79 (2012) 1397-1405
  3. Kivimäki M et al.: Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data. Lancet 380 (2012) 1491-1497
  4. Doehner W et al.: Overweigt and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observation from the TEMPiS trial. European Heart Journal (2012) (doi: 10.1093/eurheartj/ehs340)
  5. Steindorf K et al CM (2011) Welche Effekte hat körperliche Bewegung auf das Krebsrisiko und auf den Krankheitsverlauf nach einer Krebsdiagnose. Bundesgesundheitsblatt
  6. Campbell KL. Et al.: Effects of aerobic exercise training on estrogen metabolism in premenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers (2007) Prev 16:731-739
  7. Campbell PT et al.: Associations of Recreational Physical Ativity and Leisure Time Spend Sitting With Colorecral Cancer Survival. J ClinOncol(2013) online 22 Januar: doi: JCO.2012.45.9735

Genitalprolaps der Frau

„Sind Netze in der Deszensuschirurgie out?“
von PD Dr. med. Annett Gauruder-Burmester, Seiten 24-26

  1. Luber KM, Boero S, Choe JY. The demographics of pelvic floor disorders: currentobservations and future projections. Am J ObstetGynecol 2001; 184:1496-1501.
  2. Kapoor DS, Davila GW, Rosenthal RJ, Ghoniem GM. Pelvic Floor Dysfunction inmorbidly obese women: pilot study.Obesity Research 2004;1104-1107.
  3. Olsen A, Mbre L, Smith, VJ, Bergstrom JO, Colling JC, Clark A. Epidemiology ofsurgically managed pelvic organ prolapse and urinary incontinence. Obstetrics&Gynecology1997;89:493-642.
  4. www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm (letzter Zugriff: 21. Juni 2013)
  5. AWMF-Leitlinien-Registernummer: Nr. 015/006: Descensusgenitalis der Frau. Freigabe durch den Vorstand der DGGG: Juni 2008; Erstellungsdatum: 08/1998, letzte Überarbeitung: 06/2008.
  6. Skala C, Renezeder K, Albrich S et al. The IUGA/ICS classification of complicationsof prosthesis and graft insertion: a comparative experience in incontinence and prolapse surgery. IntUrogynecol J 2011;22:1429-1435.
  7. Albrich S, Naumann G, Skala C, Kölbl H. Operative Therapie des Descensusgenitalis: Was ist Standard - Was ist experimentell? GeburtshFrauenheilk 2008;68(4):353-358.
  8. Maher CM, Feiner B, Baessler K et al. Surgical management of pelvic organ prolapse in women: the updated summary version Cochrane review. IntUrogynecol J 2011; 22:1445-1457.

Schilddrüse & Schwangerschaft

Mütterliches Thyroxin, Frühgeburtlichkeit und fetale Gehirnentwicklung
von Dr. med. Elio Torremante, Seite 32-36

  1. Schleußner E. Drohende Frühgeburt: Prävention, Diagnostik und Therapie. DtschArztebl 2013; 110(13): 227-236.
  2. Goldberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371(9606):75–84.
  3. Tucker J, McGuire W. Epidemiology of preterm birth. BMJ  2004;329:675–678.
  4. Buekens P, Klebanoff M. Preterm birth research: from disillusion to the search for new mechanisms. PaediatrPerinatEpidemiol 2001;15 Suppl 2:159–61.
  5. Langhoff-Roos J, Kesmodel U, Jacobsson B, et al. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study. BMJ 2006;332(7547):937-939.
  6. Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002;360:1489–1497.
  7. Callaghan WM, Mac Dorman MF, Rasmussen SA, et al. The Contribution of Preterm Birth to Infant Mortality Rates in the United States.Pediatrics  2006;118:1566-1573.
  8. Menard JP, Mazouni C, Salem-Cherif I, et al. High vaginal concentrations of Atopobiumvaginae and Gardnerellavaginalis in women undergoing preterm labor. ObstetGynecol 2010;115(1):134-140.
  9. Romero R, Nicolaides K, Conde-Agudelo A, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J ObstetGynecol 2012; 206(2):124.e1-19.
  10. Hoekstra RE, Ferrara TB, Couser RJ, et al. Survival and long-term neurodevelopmental outcome Eur J Pediatr. 2008; 167(1):87-95.
  11. Williams J, Lee KJ, Anderson PJ. Prevalence of motor-skill impairment in preterm children who do not develop cerebral palsy: a systematic review. Dev Med Child Neurol. 2010; 52(3):232-237.
  12. Johnson S, Marlow N. Preterm birth and childhood psychiatric disorders. Pediatr Res. 2011; 69(5 Pt 2):11R-8R.
  13. MacKay DF, Smith GC, Dobbie R, et al. Gestational age at delivery and special educational need: retrospective cohort study of 407,503 schoolchildren. PLoS Med. 2010; 7(6):e1000289.
  14. Wang ML, Dorer DJ, Fleming MP, et al. Clinical outcomes of near-term infants. Pediatrics 2004; 114(2):372-376.
  15. Adams-Chapman I. Neurodevelopmental outcome of the late preterm infant. ClinPerinatol 2006; 33(4):947-964.
  16. Lee SS, Kwon HS, Choi HM. Evaluation of preterm delivery between 32-33 weeks of gestation. J Korean Med Sci 2008; 23(6):964-968.
  17. Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med 2008; 359(3):262-73.
  18. Johnson S, Hennessy E, Smith R, et al. Academic attainment and special educational needs in Outcome of extremely low birth weight survivors at school age: the influence of perinatal parameters on neurodevelopment. 2009; 94(4): F283-289.
  19. Neubauer AP, Voss W, Kattner E. Outcome of extremely low birth weight survivors at school age: the influence of perinatal parameters on neurodevelopment. Eur J Pediatr 2008; 167(1):87–95.
  20. Larroque B, Ancel PY, Marret S, et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet 2008;371(9615):813–820.
  21. Petrini JR, Dias T, McCormick MC, et al. Increased risk of adverse neurological development for late preterm infants. Pediatr 2009; 154(2):169–76.
  22. Santos IS, Matijasevich A, Domingues MR, et al. Late preterm birth is a risk factor for growth faltering in early childhood: a cohort study. BMC Pediatr 2009; 9:71.
  23. Swamy GK, Ostbye T, Skjaerven R. Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. JAMA 2008; 299(12):1429-1436.
  24. Escobar GJ, Clark RH, Greene JD. Short-term outcomes of infants born at 35 and 36 weeks gestation: we need to ask more questions. SeminPerinatol 2006; 30(1):28-33.
  25. Nulman I, Rovet J, Barrera M, et al. Long-term neurodevelopment of children exposed to maternal nausea and vomiting of pregnancy and diclectin. J Pediatr. 2009; 155(1): 45-50.
  26. Torremante P. Schilddrüse und Schwangerschaft. Frauenarzt  2002; 43 (9): 1052-1064.
  27. Torremante P. Schilddrüse und Schwangerschaft. Frauenarzt 2002; 43 (10): 1180-1196.
  28. Simon SL, Bouville A. Radiation doses to local populations near nuclear weapons test sites worldwide. Health Phys. 2002; 82(5):706-725.
  29. Torremante P. Die Schilddrüse in der gynäkologischen Sprechstunde. Menopause und Contraception 2012; 1: 1-16.
  30. Thangaratinam S, Tan A, Knox E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. 2011; 342:d2616-2622.
  31. Negro R. Thyroid insufficiency during pregnancy: complications and implications for screening. Expert Rev EndocrinMetab 2008; 3(2): 137-146.
  32. Torremante P, Flock F, Kirschner W. Free thyroxine level in the high normal reference range prescribed for nonpregnant women may reduce the preterm delivery rate in multiparous. J Thyroid Res 2011; 2011:905734.
  33. Brosco JP, Sanders LM, MD, Dowling M, et al. Impact of Specific Medical Interventions in Early Childhood on Increasing the Prevalence of Later Intellectual Disability. JAMAPediatr. 2013;167(6): 544-548. doi:10.1001/jamapediatrics.2013.1379.

Mayer-Rokitansky-Küster-Hauser-Syndrom

Vergleich verschiedener Methoden zur Fehlbildungsdiagnostik
von Dr. med. Erika Wiesinger, Dr. med. Johannes Lermann, Dr. rer. nat. Lothar Häberle, PD Dr. med. Patricia Oppelt, Dr. med. Christine Schulze, Prof. Dr. med. Sara Brucker, Prof. Dr. med. Diethelm Wallwiener, Dr. med. Katharina Heusinger,
PD Dr. med. Stefan P. Renner, Prof. Dr. med. Matthias W. Beckmann und Prof. Dr. med. Andreas Müller, Seiten 38-43

  1. Morcel K et al.The Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome: clinical description and genetics. J GynecolObstetBiolReprod (Paris), 2008; 37(6): p539-546.
  2. Morcel K, Camborieux L, Guerrier D. Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. Orphanet J Rare Dis 2007; 2: 13.
  3. Oppelt P et al. Clinical aspects of Mayer-Rokitansky-Kuester-Hauser syndrome: recommendations for clinical diagnosis and staging. Hum Reprod, 2006; 21(3): 792-797.
  4. Mayer CAJ. Über Verdopplung des Uterus und ihre Arten, nebst Bemerkungen über Hasenscharte und Wolfsrachen. J. Chir. Augenheilk 1829; 13: 525-564.
  5. Rokitansky C. Über die sogenannten Verdopplungen des Uterus. Med. Jahrb. Öst. Staat 1838; 26: 39-46.
  6. Küster H. Uterus bipartitussolidusrudimentarius cum vaginasolida. Z. Geburtshilfe Gynäkol 1910; 67: 692-718.
  7. Hauser GA, Schreiner WE. Mayer-Rokitansky-Kuestersyndrome. Rudimentary solid bipartite uterus with solid vagina.Schweiz Med Wochenschr 1961; 91: 381-384.
  8. Oppelt P et al. The VCUAM (Vagina Cervix Uterus Adnex-associated Malformation) classification: a new classification for genital malformations. Fertil Steril 2005; 84(5): 1493-1497.
  9. AWMF-Leitlinie "Weibliche genitale Fehlbildungen", 2010: www.awmf.org.
  10. Oppelt P et al. Female genital malformations and their associated abnormalities.FertilSteril 2007; 87(2): 335-342.
  11. Singh G, Sunita V. Double uteri with cervicovaginal agenesis. FertilSteril 2008; 90(5): p2016 e13-5.
  12. Feng F et al. Magnetic resonance imaging of congenital vaginal anomalies.Zhongguo Yi XueKeXue Yuan XueBao 2005; 27(1): 103-107.
  13. Strubbe EH et al. Mayer-Rokitansky-Kuster-Hauser syndrome: distinction between two forms based on excretory urographic, sonographic, and laparoscopic findings. AJR Am J Roentgenol 1993; 160(2): 331-334.
  14. Breech LL, Laufer MR. Mullerian anomalies. ObstetGynecolClin North Am2009; 36(1): 47-68.
  15. Croak AJ et al. Therapeutic strategies for vaginal Mullerian agenesis. J ReprodMed 2003; 48(6): 395-401.
  16. Buttram VC Jr., Gibbons WE.Mullerian anomalies: a proposed classification. Analysis of 144 cases. FertilSteril 1979; 32(1): 40-46.
  17. Brucker SY et al. Neovagina creation in vaginal agenesis: development of a new laparoscopic Vecchietti-based procedure and optimized instruments in a prospective comparative interventional study in 101 patients. FertilSteril 2008; 90(5): 1940-1952.
  18. Gauwerky JF, Wallwiener D, Bastert G. An endoscopically assisted technique for construction of a neovagina. Arch GynecolObstet 1992; 252(2):59-63.
  19. VecchiettiG. Le néo-vagindans le syndrome di Rokitansky-Küster-Hauser. Rev. Méd. Suisse Romande 1979; 99: 593-601.
  20. Brucker S, Aydeniz B, Gegusch M, Wallwiener D, Zubke W. Improvement of endoscopically assisted neovagina: new application instruments and traction device. GynecolSurg 2004;1:133-138.
  21. Brennan RL, Prediger DJ. Coefficient Kappa: Some uses, misuses, andalternatives. Educational and Psychological Measurement 1981; 41: 687-699.
  22. Troiano RN, McCarthy SM. Mullerian duct anomalies: imaging and clinical issues. Radiology 2004; 233(1): 19-34.
  23. Pellerito JS et al. Diagnosis of uterine anomalies: relative accuracy of MR imaging, endovaginalsonography, and hysterosalpingography. Radiology1992; 183(3): 795-800.
  24. CarringtonBM et al. Mullerian duct anomalies: MR imaging evaluation.Radiology 1990; 176(3):715-720.
  25. Fedele L et al. Magnetic resonance evaluation of double uteri.ObstetGynecol1989; 74(6): 844-847.
  26. Pompili G et al.Magnetic resonance imaging in the preoperative assessment of Mayer-Rokitansky-Kuster-Hauser syndrome.Radiol Med 2009; 114(5): 811-826.
  27. RosenbergHK et al.Mayer-Rokitansky-Kuster-Hauser syndrome: US aid to diagnosis. Radiology1986; 161(3): 815-819.
  28. Soares SR, Barbosa dos Reis MM, Camargos AF.Diagnostic accuracy of sonohysterographytransvaginalsonography and hysterosalpingography in patients with uterine cavity diseases.FertilSteril 2000; 73(2): 406-411.
  29. Lang IM, Babyn P, Oliver GD.MR imaging of paediatricuterovaginal anomalies. PediatrRadiol 1999; 29(3): 163-170.